ONE-WAYOngoing theme · still written in the latest filings
Fixed Asset Impairment Associated with Estimates of Regulatory Approvals and Growth for the Life Science Clinical Testing Device Business
A matter concerning the Life Science business's clinical testing devices, where estimates of early commercialization, market growth, customer sales, competitiveness and regulatory approvals affect the recoverability of fixed assets and impairment losses.
Companies2How many companies write about this.
Threads2One company can carry more than one thread here.
PeriodFY2023 →Still being written about.
Directionhurts0 helps · 2 hurts · 0 flat